1. Home
  2. IDAI vs SPRC Comparison

IDAI vs SPRC Comparison

Compare IDAI & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDAI
  • SPRC
  • Stock Information
  • Founded
  • IDAI 2016
  • SPRC 2004
  • Country
  • IDAI United States
  • SPRC Israel
  • Employees
  • IDAI N/A
  • SPRC N/A
  • Industry
  • IDAI Computer Software: Prepackaged Software
  • SPRC Biotechnology: Pharmaceutical Preparations
  • Sector
  • IDAI Technology
  • SPRC Health Care
  • Exchange
  • IDAI Nasdaq
  • SPRC Nasdaq
  • Market Cap
  • IDAI 7.7M
  • SPRC 7.3M
  • IPO Year
  • IDAI N/A
  • SPRC N/A
  • Fundamental
  • Price
  • IDAI $3.64
  • SPRC $4.29
  • Analyst Decision
  • IDAI Strong Buy
  • SPRC
  • Analyst Count
  • IDAI 1
  • SPRC 0
  • Target Price
  • IDAI $12.00
  • SPRC N/A
  • AVG Volume (30 Days)
  • IDAI 1.7M
  • SPRC 7.1M
  • Earning Date
  • IDAI 11-14-2025
  • SPRC 01-01-0001
  • Dividend Yield
  • IDAI N/A
  • SPRC N/A
  • EPS Growth
  • IDAI N/A
  • SPRC N/A
  • EPS
  • IDAI N/A
  • SPRC N/A
  • Revenue
  • IDAI $3,366,415.00
  • SPRC $1,306,000.00
  • Revenue This Year
  • IDAI $25.13
  • SPRC N/A
  • Revenue Next Year
  • IDAI $164.45
  • SPRC N/A
  • P/E Ratio
  • IDAI N/A
  • SPRC N/A
  • Revenue Growth
  • IDAI N/A
  • SPRC N/A
  • 52 Week Low
  • IDAI $1.43
  • SPRC $1.75
  • 52 Week High
  • IDAI $18.75
  • SPRC $37.59
  • Technical
  • Relative Strength Index (RSI)
  • IDAI 64.41
  • SPRC 51.31
  • Support Level
  • IDAI $3.50
  • SPRC $3.23
  • Resistance Level
  • IDAI $4.07
  • SPRC $4.62
  • Average True Range (ATR)
  • IDAI 0.29
  • SPRC 0.64
  • MACD
  • IDAI 0.05
  • SPRC -0.13
  • Stochastic Oscillator
  • IDAI 66.35
  • SPRC 29.47

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: